Adaptation of Pseudomonas aeruginosa to the chronic phenotype by mutations in the algTmucABD operon in isolates from Brazilian cystic fibrosis patients

Natália Candido Caçador*, Carolina Paulino da Costa Capizzani, Lídia Alice Gomes Monteiro Marin Torres, Renata Galetti, Oana Ciofu, Ana Lúcia da Costa Darini, Niels Høiby

*Corresponding author for this work
    13 Citations (Scopus)
    79 Downloads (Pure)

    Abstract

    Chronic lung infection by Pseudomonas aeruginosa is the leading cause of morbidity and mortality in cystic fibrosis (CF) patients. This is associated with the conversion of the non-mucoid to the mucoid phenotype. However, there is little information about the occurrence of alginate-producing P. aeruginosa in CF patients outside Europe and North America. The aim of the present study was to investigate mutations in the algTmucABD operon in mucoid and non-mucoid isolates from Brazilian CF patients. Twenty-seven mucoid and 37 non-mucoid isolates from 40 CF patients chronically infected by P. aeruginosa attending a CF reference center in Brazil were evaluated by sequence analysis. Mutations in mucA were observed in 93% of the mucoid isolates and 54% of the non-mucoid isolates. Among these non-mucoid isolates, 55% were considered revertants, since they also had mutations in algT (algU). Most isolates associated with moderate alginate production presented point mutations in mucB and/or mucD. We identified 30 mutations not previously described in the operon. In conclusion, mutations in mucA were the main mechanism of conversion to mucoidy, and most of the non-mucoid isolates were revertants, but the mechanism of revertance is not fully explained by changes in algT.

    Original languageEnglish
    Article numbere0208013
    JournalPLoS ONE
    Volume13
    Issue number11
    Number of pages11
    ISSN1932-6203
    DOIs
    Publication statusPublished - 2018

    Fingerprint

    Dive into the research topics of 'Adaptation of Pseudomonas aeruginosa to the chronic phenotype by mutations in the algTmucABD operon in isolates from Brazilian cystic fibrosis patients'. Together they form a unique fingerprint.

    Cite this